Nationwide population-based epidemiological study of myasthenia gravis in Taiwan

Neuroepidemiology

Volumn 35, Issue 1, 2010, Pages 66-71

  Lai, Chien Hsu ^a   Tseng, Hung Fu ^b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAISER PERMANENTE   (United States)

Author keywords

Medical expenses; Myasthenia gravis, incidence prevalence; Taiwan, epidemiology; Thymus disorders

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE COST; HUMAN; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYASTHENIA GRAVIS; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; TAIWAN; AGE; ECONOMICS; FACTUAL DATABASE; INCIDENCE; MIDDLE AGED; NEWBORN; PREVALENCE; VERY ELDERLY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREVALENCE; SEX FACTORS; TAIWAN;

EID: 77952993756     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000311012     Document Type: Article

References (35)

1. Bird SJ: Clinical manifestations of myasthenia gravis. http://www.uptodate.com. Accessed on Dec 20, 2008.
2. Grob D, Brunner N, Namba T, Pagala M: Lifetime course of myasthenia gravis. Muscle Nerve 2008; 37: 141-149.
3. Phillips LH: The epidemiology of myasthenia gravis. Semin Neurol 2004; 24: 17-20.
4. Phillips LH 2nd: The epidemiology of myasthenia gravis. Ann NY Acad Sci 2003; 998: 407-412.
5. Vincent A, Clover L, Buckley C, Grimley Evans J, Rothwell PM: Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry 2003; 74: 1105-1108.
6. Somnier FE: Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis. Neurology 2005; 65: 928-930.
7. Aragones JM, Bolibar I, Bonfill X, Bufill E, Mummany A, Alonso F, Illa I: Myasthenia gravis: a higher than expected incidence in the elderly. Neurology 2003; 60: 1024-1026.
8. Matsuda M, Dohi-Iijima N, Nakamura A, Sekijima Y, Morita H, Matsuzawa S, Sato S, Yahikozawa H, Tabata K, Yanagawa S, Ikeda S: Increase in incidence of elderly-onset patients with myasthenia gravis in Nagano Prefecture, Japan. Intern Med 2005; 44: 572-577.
9. Lai CH, Tseng HF: Epidemiology and medical expenses of motor neuron diseases in Taiwan. Neuroepidemiology 2008; 31: 159-166.
10. Lai CH, Tseng HF: Population-based epidemiological study of neurological diseases in Taiwan. I. Creutzfeldt-Jakob disease and multiple sclerosis. Neuroepidemiology 2009; 33: 247-253.
11. Lai CH, Tseng HF: Population-based epidemiologic study of Wilson's disease in Taiwan. Eur J Neurol 2010, E-pub ahead of print.
12. Meriggioli MN, Sanders DB: Myasthenia gravis: diagnosis. Semin Neurol 2004; 24: 31-39.
13. Vincent A, Newsom-Davis J: Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2,967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985; 48: 1246-1252.
14. Oh SJ, Kim DE, Kuruoglu R, Bradley RJ, Dwyer D: Diagnostic sensitivity of the laboratory tests in myasthenia gravis. Muscle Nerve 1992; 15: 720-724.
15. Poulas K, Tsibri E, Kokla A, Papanastasiou D, Tsouloufis T, Marinou M, Tsantili P, Papapetropoulos T, Tzartos SJ: Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 2001; 71: 352-356.
16. Storm-Mathisen A: Epidemiological and prognostical aspects of myasthenia gravis in Norway. Ann NY Acad Sci 1966; 135: 431-435.
17. Garland H, Clark AN: Myasthenia gravis; a personal study of 60 cases. Br Med J 1956; 1: 1259-1262.
18. Giagheddu M, Puggioni G, Sanna G, Tamburini G, Marrosu F, Rachele MG, Murgia B, Rosati G: Epidemiological study of myasthenia gravis in Sardinia, Italy (1958-1986). Acta Neurol Scand 1989; 79: 326-333.
19. Oosterhuis HJ: The natural course of myasthenia gravis: a long-term follow-up study. J Neurol Neurosurg Psychiatry 1989; 52: 1121-1127.
20. Pirskanen R: Genetic aspects in myasthenia gravis: a family study of 264 Finnish patients. Acta Neurol Scand 1977; 56: 365-388.
21. Storm-Mathisen A: Epidemiology of myasthenia gravis in Norway. Acta Neurol Scand 1984; 70: 274-284.
22. Phillips LH 2nd, Torner JC, Anderson MS, Cox GM: The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992; 42: 1888-1893.
23. Somnier FE, Keiding N, Paulson OB: Epidemiology of myasthenia gravis in Denmark: a longitudinal and comprehensive population survey. Arch Neurol 1991; 48: 733-739.
24. Somnier FE: Myasthenia gravis. Dan Med Bull 1996; 43: 1-10.
25. Yu YL, Hawkins BR, Ip MS, Wong V, Woo E: Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease. Acta Neurol Scand 1992; 86: 113-119.
26. Christensen PB, Jensen TS, Tsiropoulos I, Sorensen T, Kjaer M, Hojer-Pedersen E, Rasmussen MJ, Lehfeldt E, de Fine Olivarius B: Incidence and prevalence of myasthenia gravis in western Denmark: 1975 to 1989. Neurology 1993; 43: 1779-1783.
27. Lavrnic D, Jarebinski M, Rakocevic-Stojanovic V, Stevic Z, Lavrnic S, Pavlovic S, Trikic R, Tripkovic I, Neskovic V, Apostolski S: Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992). Acta Neurol Scand 1999; 100: 168-174.
28. Tola MR, Caniatti LM, Casetta I, Granieri E, Conighi C, Quatrale R, Monetti VC, Paolino E, Govoni V, Pascarella R, et al: Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand 1994; 90: 318-323.
29. Robertson NP, Deans J, Compston DA: Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998; 65: 492-496.
30. Oopik M, Kaasik AE, Jakobsen J: A population based epidemiological study on myasthenia gravis in Estonia. J Neurol Neurosurg Psychiatry 2003; 74: 1638-1643.
31. Thanvi BR, Lo TC: Update on myasthenia gravis. Postgrad Med J 2004; 80: 690-700.
32. Zhang X, Yang M, Xu J, Zhang M, Lang B, Wang W, Vincent A: Clinical and serological study of myasthenia gravis in Hubei Province, China. J Neurol Neurosurg Psychiatry 2007; 78: 386-390.
33. Chiu HC, Vincent A, Newsom-Davis J, Hsieh KH, Hung T: Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology 1987; 37: 1854-1857.
34. Phillips LH 2nd, Torner JC: Epidemiologic evidence for a changing natural history of myasthenia gravis. Neurology 1996; 47: 1233-1238.
35. McGrogan A, Sneddon S, de Vries CS: The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology 2010; 34: 171-183.